Drug intelligence / Profile preview

3-[[(3R,4S,5S,6R)-7-benzyl-4,5-dihydroxy-1,1-dioxo-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepan-2-yl]methyl]-N-methylbenzamide

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule belonging to the benzamide class. It features a thiadiazepane ring system with multiple chiral centers and phenoxymethyl substituents. The molecule has been cataloged in chemical and drug databases (PubChem CID 445754; DrugBank DB03076; ChEMBL357057) as an experimental or research compound. There are no approved medical indications or clinical trials reported for this substance as of June 2025. Its mechanism of action and biological targets have not been characterized in the literature or major pharmacological databases[1][2][5].

Other names
3-{[(3R,4S,5S,6R)-7-benzyl-4,5-dihydroxy-1lambda6,2,7-thiadiazepan-2-yl]methyl}-N-methylbenzamide3-(7-benzyl-4,5-dihydroxy-1lambda6-[1,2,7]thiadiazepan–2–ylmethyl)-N-methylbenzamide

Beyond the preview

Go deeper on 3-[[(3R,4S,5S,6R)-7-benzyl-4,5-dihydroxy-1,1-dioxo-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepan-2-yl]methyl]-N-methylbenzamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-[[(3R,4S,5S,6R)-7-benzyl-4,5-dihydroxy-1,1-dioxo-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepan-2-yl]methyl]-N-methylbenzamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call